These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 14624074)

  • 21. [Gene therapy for brain tumors--present conditions and prospects].
    Nakahara N; Yoshida J
    Gan To Kagaku Ryoho; 2005 Apr; 32(4):458-62. PubMed ID: 15853210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene therapy for gliomas: molecular targets, adenoviral vectors, and oncolytic adenoviruses.
    Alemany R; Gomez-Manzano C; Balagué C; Yung WK; Curiel DT; Kyritsis AP; Fueyo J
    Exp Cell Res; 1999 Oct; 252(1):1-12. PubMed ID: 10502394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine therapy for melanoma: current status and future directions.
    Terando AM; Faries MB; Morton DL
    Vaccine; 2007 Sep; 25 Suppl 2():B4-16. PubMed ID: 17646038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy for malignant glioma.
    Lesniak MS
    Expert Rev Neurother; 2006 Apr; 6(4):479-88. PubMed ID: 16623647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer immunogene therapy.
    Yoshizawa H; Kagamu H; Gejyo F
    Arch Immunol Ther Exp (Warsz); 2001; 49(5):337-43. PubMed ID: 11798131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses.
    Maxwell R; Luksik AS; Garzon-Muvdi T; Lim M
    Curr Neurol Neurosci Rep; 2017 Jun; 17(6):50. PubMed ID: 28488122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poxviruses as vectors for cancer immunotherapy.
    Kwak H; Hörig H; Kaufman HL
    Curr Opin Drug Discov Devel; 2003 Mar; 6(2):161-8. PubMed ID: 12669450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Locoregional therapies for glioma.
    Mamelak AN
    Oncology (Williston Park); 2005 Dec; 19(14):1803-10; discussion 1810, 1816-7, 1821-2. PubMed ID: 16506634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biologic therapy for brain cancers--based on cellular and immunobiology.
    Okada H
    Yonsei Med J; 2004 Jun; 45 Suppl():68-70. PubMed ID: 15250054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer-germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment.
    Gjerstorff MF; Burns J; Ditzel HJ
    Expert Opin Biol Ther; 2010 Jul; 10(7):1061-75. PubMed ID: 20420535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV.
    Toda M; Iizuka Y; Kawase T; Uyemura K; Kawakami Y
    Cancer Gene Ther; 2002 Apr; 9(4):356-64. PubMed ID: 11960286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune and viral therapies for malignant primary brain tumors.
    Gardeck AM; Sheehan J; Low WC
    Expert Opin Biol Ther; 2017 Apr; 17(4):457-474. PubMed ID: 28274139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma.
    Miletic H; Fischer YH; Giroglou T; Rueger MA; Winkeler A; Li H; Himmelreich U; Stenzel W; Jacobs AH; von Laer D
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6761-8. PubMed ID: 18006778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy for mesothelioma and lung cancer.
    Vachani A; Moon E; Wakeam E; Albelda SM
    Am J Respir Cell Mol Biol; 2010 Apr; 42(4):385-93. PubMed ID: 20160042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide-based immunotherapeutic approaches to glioma: a review.
    Yamanaka R; Itoh K
    Expert Opin Biol Ther; 2007 May; 7(5):645-9. PubMed ID: 17477802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trials of viral therapy for malignant gliomas.
    Piccioni DE; Kesari S
    Expert Rev Anticancer Ther; 2013 Nov; 13(11):1297-305. PubMed ID: 24138481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen-receptor gene-modified T cells for treatment of glioma.
    Ikeda H; Shiku H
    Adv Exp Med Biol; 2012; 746():202-15. PubMed ID: 22639170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Animal models for vaccine therapy.
    Chung DS; Kim CH; Hong YK
    Adv Exp Med Biol; 2012; 746():143-50. PubMed ID: 22639165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single vs. combination immunotherapeutic strategies for glioma.
    Chandran M; Candolfi M; Shah D; Mineharu Y; Yadav VN; Koschmann C; Asad AS; Lowenstein PR; Castro MG
    Expert Opin Biol Ther; 2017 May; 17(5):543-554. PubMed ID: 28286975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modifying adenoviral vectors for use as gene-based cancer vaccines.
    Basak SK; Kiertscher SM; Harui A; Roth MD
    Viral Immunol; 2004; 17(2):182-96. PubMed ID: 15279698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.